By Trevor Damyan, Commercial Mortgage Broker at Commercial Lending Solutions
Skilled nursing facility (SNF) financing operates in a specialized healthcare CRE niche dominated by HUD 232 long-term financing, a small bench of specialty healthcare lenders, and growing private credit interest. SNFs serve residents requiring skilled nursing care, typically funded by Medicare (short-stay) and Medicaid (long-stay), with operations subject to extensive federal and state regulatory oversight. The financing market reflects the regulatory complexity, reimbursement risk, and operational sophistication required for SNF operations.
Get a SNF Quote →SNF financing leans heavily on HUD 232 for long-term hold strategies, supplemented by specialty healthcare lenders, conventional bank balance sheet for shorter-term opportunistic transactions, and private credit for value-add and turnaround scenarios.
Pricing is indicative and reflects active CLS CRE quote pipeline as of April 2026. Actual pricing depends on property condition, sponsor profile, deal size, and market dynamics.
SNF transactions range from $3M for small rural facilities to $50M+ for trophy multi-facility metro portfolios. Per-bed pricing varies enormously: rural SNF at $30,000 to $60,000 per bed, suburban SNF at $60,000 to $150,000 per bed, urban Class A SNF at $150,000 to $300,000 per bed.
Sponsor profiles include institutional SNF operators (Genesis Healthcare, Ensign Group, Brookdale, others), regional SNF chains, family-owned operators (often multi-generational), and SNF REITs (Sabra Health Care REIT, CareTrust REIT, Omega Healthcare). The asset class consolidates steadily but remains substantially fragmented at the operator level.
Operating revenue is dominated by Medicare reimbursement for short-stay rehabilitation patients (typically 30 to 50% of revenue, higher per-day rates), Medicaid for long-stay residents (35 to 55% of revenue, lower per-day rates), and private pay (5 to 25% of revenue, highest per-day rates). Reimbursement mix materially affects operating economics.
SNF underwriting evaluates the property, the operator, the regulatory environment, and the reimbursement profile. The asset class requires specialized lender expertise.
SNF transactions have specific failure modes around regulatory enforcement, reimbursement changes, and operator quality issues.
On a $14M acquisition of a 132-bed skilled nursing facility in a Sun Belt suburban market, the buyer was an institutional SNF operator with 18 facilities and a four-star CMS rating average. The acquisition was financed through specialty healthcare lender at 8.45 percent fixed 7-year, 70 percent LTV ($9.8M loan amount), with sponsor recourse and full performance covenants tied to census, CMS rating, and DSCR. The deal closed in 110 days. After 14 months of operating, the sponsor refinanced into HUD 232 at 6.15 percent fixed 35-year fully amortizing at 78 percent LTV ($11M loan amount), returning $1.2M of capital and locking in long-term cost of capital.
All deal references anonymize borrower and lender identities and use city-level geography only.
SNF financing is one of the most regulated corners of healthcare CRE. The HUD 232 program is the gold standard for long-term holds, but the 12 to 24 month underwriting timeline makes it incompatible with opportunistic acquisitions. Specialty healthcare lenders bridge the gap.
Tell us about your snf deal. We will run it past lenders that actively fund this property type and send back terms within 48 hours.
Apply for Financing →